Sign In
Buy BLUE
$4.97
+0 (+0%)
At Close: Aug 29, 2025
bluebird bio Inc (NASDAQ:BLUE) Shares Purchased by Geode Capital Management LLC
09:32am, Tuesday, 07'th Apr 2020
Geode Capital Management LLC lifted its stake in bluebird bio Inc (NASDAQ:BLUE) by 3.0% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 637,323
bluebird bio Inc (NASDAQ:BLUE) Shares Sold by Bank of New York Mellon Corp
08:56am, Tuesday, 07'th Apr 2020
Bank of New York Mellon Corp decreased its holdings in bluebird bio Inc (NASDAQ:BLUE) by 1.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. Th
Is Azul S.A. (AZUL) A Good Stock To Buy?
02:06am, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Hedge Funds Have Never Been This Bullish On Millicom International Cellular S.A. (TIGO)
02:06am, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Is Telecom Argentina S.A. (TEO) Going to Burn These Hedge Funds?
02:06am, Tuesday, 07'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
BidaskClub Downgrades bluebird bio (NASDAQ:BLUE) to Strong Sell
07:24am, Monday, 06'th Apr 2020
bluebird bio (NASDAQ:BLUE) was downgraded by BidaskClub from a “sell” rating to a “strong sell” rating in a note issued to investors on Saturday, BidAskClub reports. A number of other equities
Is bluebird bio Inc (BLUE) A Good Stock To Buy?
01:02am, Monday, 06'th Apr 2020
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Advisors Asset Management Inc. Reduces Stake in bluebird bio Inc (NASDAQ:BLUE)
08:06am, Sunday, 05'th Apr 2020
Advisors Asset Management Inc. lowered its stake in bluebird bio Inc (NASDAQ:BLUE) by 18.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exch
Stocks To Watch: OPEC Goes Virtual
01:04pm, Saturday, 04'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
7 Promising Biotech Stocks in a Postpandemic World
10:34pm, Friday, 03'rd Apr 2020
Casdin Capital’s Eli Casdin highlights seven promising life-sciences stocks, including bluebird bio, Invitae, and Crispr Therapeutics
FACTBOX-Coronavirus hits drugmakers as clinical trials delayed
06:45pm, Friday, 03'rd Apr 2020
Drugmakers have started to delay or pause trials testing their treatments and therapies as the
new coronavirus puts a strain on hospitals, and doctors follow social-distancing protocol.
The delay
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More
12:21pm, Friday, 03'rd Apr 2020
The coronavirus pandemic has shaken the global economy, but three life sciences venture capital firms this week announced new funds totaling nearly $3
Bank of America Corp DE Sells 86,595 Shares of bluebird bio Inc (NASDAQ:BLUE)
10:02am, Friday, 03'rd Apr 2020
Bank of America Corp DE cut its stake in bluebird bio Inc (NASDAQ:BLUE) by 32.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commi
bluebird bio Inc (NASDAQ:BLUE) Shares Sold by Brinker Capital Inc.
09:04am, Friday, 03'rd Apr 2020
Brinker Capital Inc. decreased its position in shares of bluebird bio Inc (NASDAQ:BLUE) by 38.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Ex
Bristol Myers, bluebird Submit BLA for Myeloma Drug to FDA
03:50pm, Wednesday, 01'st Apr 2020
Bristol Myers (BMY) and bluebird file a biologics license application to the FDA seeking approval of idecabtagene vicleucel for heavily pre-treated patients with multiple myeloma. Stock gains.
